10 January 2008
Director's Share Transfer
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces the following transfer of ordinary shares in the Company by Anthony Clayden, Finance Director. There is no change in Mr Clayden's total shareholding in the Company, or the beneficial ownership of Mr Clayden’s shares, as a result of the transfer. On 9 January 2008, Mr Clayden authorised the transfer of 240,305 of his ordinary shares in the Company into his Hargreaves Lansdown Vantage Fund and Share account.
For any further information please contact:
Futura Medical plc
James Barder, Chief Executive
+44 (0) 1483 685 670
james.barder@futuramedical.co.uk
www.futuramedical.co.uk
Nominated Adviser:
Canaccord Adams Limited
Mark Williams / Erin Needra
Tel: +44 (0) 20 7050 6500
For any media enquiries please contact:
Buchanan Communications Limited
Mark Court
markc@buchanan.uk.com
Rebecca Skye Dietrich
rebeccad@buchanan.uk.com
+44 (0) 20 7466 5000